Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 25;54(11):1740-1747.
doi: 10.3724/abbs.2022169.

A truncated mutation of MucA in Pseudomonas aeruginosa from a bronchiectasis patient affects T3SS expression and inflammasome activation

Affiliations

A truncated mutation of MucA in Pseudomonas aeruginosa from a bronchiectasis patient affects T3SS expression and inflammasome activation

Yanan Liu et al. Acta Biochim Biophys Sin (Shanghai). .

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that causes chronic airway infection in bronchiectasis patients and is closely associated with poor prognosis. Strains isolated from chronically infected patients typically have a mucoid phenotype due to the overproduction of alginate. In this study, we isolate a P. aeruginosa strain from the sputum of a patient with bronchiectasis and find that a truncated mutation occurred in mucA, which is named mucA117. mucA117 causes the strain to transform into a mucoid phenotype, downregulates the expression of T3SS and inflammasome ligands such as fliC and allows it to avoid inflammasome activation. The truncated mutation of the MucA protein may help P. aeruginosa escape clearance by the immune system, enabling long-term colonization.

Keywords: MucA; Type III secretion systems; bronchiectasis; inflammasome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

None
Figure 1
P. aeruginosa strain L012 is mucoid colonies and a truncated mutation of mucA occurs in strain L012 (A) P. aeruginosa strains PAO1 and L012 were grown on LB agar and imaged after 24 h to observe mucus formation. (B) Schematic diagram of the MucA structure. Green, AlgU binding domain (AlgU BD); yellow, the transmembrane domain (TM); and blue, the MucB binding domain (MucB BD). The red line indicates the mutation position of P. aeruginosa strain L012, and the green line indicates the mutation position of mucA22.
None
Figure 2
mucA117 turns the strain into mucoid and reduces the its ability to induce pyroptosis and the activation of inflammasomes in PMs (A) The P. aeruginosa strains PAO1Δ mucA/EV, PAO1Δ mucA/PAO1 mucA, PAO1Δ mucA/L012 mucA, L012/EV and L012/PAO1 mucA were grown on LB agar without arabinose and imaged after 24 h to observe mucus formation. (B) PMs were infected with PAO1, PAO1Δ mucA/EV, PAO1Δ mucA/PAO1 mucA and PAO1Δ mucA/L012 mucA (MOI=10) for 6 h. Cell death was determined by measuring the LDH released into the supernatants. (C) Caspase-1 cleavage in the supernatants and cell lysates of PMs infected with PAO1, PAO1Δ mucA/EV, PAO1Δ mucA/PAO1 mucA and PAO1Δ mucA/L012 mucA for 6 h. * P<0.05, ** P<0.01 (unpaired t test).
None
Figure 3
mucA117 downregulates the expression of T3SS and inflammasome ligand, which may be related to the increased expressions of algU and algR (A) Under T3SS induction conditions, the PcrV levels in the P. aeruginosa strains PAO1, PAO1Δ mucA/EV, PAO1Δ mucA/PAO1 mucA, PAO1Δ mucA/L012 mucA, L012/EV and L012/PAO1 mucA were detected in culture supernatants and whole-cell extracts. (B) Relative expression of pcrV, fliC, algU and algR in these strains. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 (unpaired t test).

Similar articles

Cited by

References

    1. Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections . Drugs Context. . 2018;7:212527. doi: 10.7573/dic.212527. - DOI - PMC - PubMed
    1. Broder UN, Jaeger T, Jenal U. LadS is a calcium-responsive kinase that induces acute-to-chronic virulence switch in Pseudomonas aeruginosa . Nat Microbiol. . 2016;2:16184. doi: 10.1038/nmicrobiol.2016.184. - DOI - PubMed
    1. Faure E, Kwong K, Nguyen D. Pseudomonas aeruginosa in chronic lung infections: how to adapt within the host? . Front Immunol. . 2018;9:2416. doi: 10.3389/fimmu.2018.02416. - DOI - PMC - PubMed
    1. Malhotra S, Hayes Jr. D, Wozniak DJ. Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface . Clin Microbiol Rev. . 2019;32:e00138-18. doi: 10.1128/CMR.00138-18. - DOI - PMC - PubMed
    1. Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. . 2018;6:715–726. doi: 10.1016/S2213-2600(18)30053-5. - DOI - PubMed